Clinical trial

Lung-MAP S1400K: c-MET Positive

NCT03574753

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-03-16

PhasePHASE2

Study timeline

Study start (actual)2018-03-16Date precision: day

Registry last updated2021-10-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Recurrent Squamous Cell Lung Carcinomaunresolved

Stage IV Squamous Cell Lung Carcinoma AJCC V7unresolved

Interventions

ABBV-399DRUG

Sponsors & collaborators

SWOG Cancer Research Networklead sponsor

Mapped research locations

HoustonTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03574753 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.